Rebif, or Interferon beta-1a, is a prescription drug that reduces frequency of relapses in people who have multiple sclerosis (MS). Also delays some of the physical disabilities caused by MS. Assett, an agency who works with Merek Serono, wanted me to make an app that showcased to Italian doctors why Rebif might be the best choice for their patients.
Art Direction: “Make it clean and flat. Green and white. Emphasis on the graphs.”